Ironwood Pharmaceuticals, Inc

(NASDAQ:IRWD)

Latest On Ironwood Pharmaceuticals, Inc (IRWD):

Date/Time Type Description Signal Details
2023-05-22 08:54 ESTNewsIronwood falls 15% on deal to buy VectivBio for $17/share cashN/A
2023-05-07 06:21 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 13:18 ESTNewsIronwood Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.01, revenue of $104.06M beats by $3.46MN/A
2023-05-04 00:56 ESTNewsIronwood Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-13 22:50 ESTNewsIronwood Pharmaceuticals gains amid activist speculationN/A
2023-04-11 15:09 ESTNewsIronwood Pharmaceuticals to eliminate COO roleN/A
2023-02-16 14:50 ESTNewsIronwood Pharmaceuticals Non-GAAP EPS of $0.27 beats by $0.01, revenue of $107.2M misses by $1.02M, guidance in-lineN/A
2023-02-16 14:50 ESTNewsIronwood Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-16 14:49 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) Q4 2022 Earnings Call TranscriptN/A
2023-02-13 07:56 ESTNewsAbbVie, Ironwood Linzess gets FDA priority review to treat functional constipation in childrenN/A
2023-01-12 23:21 ESTNewsIronwood Pharmaceuticals (IRWD) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- SlideshowN/A
2022-11-04 04:11 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) Q3 2022 Earnings Call TranscriptN/A
2022-11-03 10:50 ESTNewsIronwood Pharmaceuticals Non-GAAP EPS of $0.28 beats by $0.01, revenue of $108.64M misses by $1.76M, reaffirms FY guidanceN/A
2022-10-05 22:54 ESTNewsIronwood Pharmaceuticals: Rinse, Wash And RepeatN/A
2022-09-06 10:21 ESTNewsAbbVie, Ironwood constipation therapy Linzess meets main goal of phase 3 trial in childrenN/A
2022-08-06 10:54 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 19:46 ESTNewsIronwood Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 12:40 ESTNewsIronwood Pharmaceuticals reports Q2 earnings miss; reaffirms FY22 guidanceN/A
2022-08-03 22:08 ESTNewsIronwood Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-30 04:58 ESTNewsIronwood Pharma falls 7% as Linzess Q2 sales of drug from AbbVie weighN/A
2022-05-08 17:53 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-06 04:09 ESTNewsIronwood Pharmaceuticals Non-GAAP EPS of $0.21, revenue of $98MN/A
2022-05-05 04:57 ESTNewsIronwood Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-22 13:29 ESTNewsIronwood Pharmaceuticals initiated at overweight at Piper on cash flow from LinzessN/A
2022-02-18 16:15 ESTNewsIronwood Pharmaceuticals, Inc.'s (IRWD) CEO Thomas McCourt on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-17 19:01 ESTNewsIronwood Pharmaceuticals Non-GAAP EPS of $0.27 misses by $0.07, revenue of $117.13M beats by $6.96MN/A
2022-02-17 19:01 ESTNewsIronwood Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-17 19:01 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) CEO Thomas McCourt on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-16 22:26 ESTNewsIronwood Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-01-15 01:26 ESTNewsIronwood Pharmaceuticals (IRWD) presents at JP Morgan 40th Annual Virtual Healthcare Conference (Slideshow)N/A
2022-01-10 21:10 ESTNewsIronwood Pharmaceuticals sees FY21 guidance ahead of prior levels, provides FY22 estimatesN/A
2021-12-01 23:58 ESTNewsIronwood names Sravan Emany as CFON/A
2021-12-01 23:57 ESTNewsIronwood Pharmaceuticals gains on takeout speculation with CFO hiringN/A
2021-11-06 22:18 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-05 08:07 ESTNewsIronwood Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-04 11:05 ESTNewsIronwood Pharmaceuticals EPS beats by $0.01, misses on revenueN/A
2021-11-04 11:05 ESTNewsIronwood inks collaboration and license option agreement with COUR PharmaceuticalN/A
2021-11-03 13:59 ESTNewsIronwood Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-09-27 19:35 ESTNewsIronwood Pharmaceuticals: Undervalued Company With Steady GrowthN/A
2021-08-26 14:54 ESTNewsIronwood Pharma pops 7% on FDA approval of revised Lizness labelN/A
2021-08-10 06:03 ESTNewsIronwood Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-08 14:03 ESTNewsIronwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 05:08 ESTNewsIronwood Pharmaceuticals EPS beats by $0.12, beats on revenueN/A
2021-08-05 06:49 ESTNewsIronwood Pharmaceuticals Q2 2021 Earnings PreviewN/A
2021-07-21 12:48 ESTNewsIronwood Pharma announces agreement with Teva for generic version of LINZESSN/A
2021-07-21 12:45 ESTNewsIronwood Pharmaceuticals names Thomas McCourt permanent CEON/A
2021-07-21 12:33 ESTNewsIronwood Pharmaceuticals gains on takeover speculation after 8-K filing (update)N/A
2021-05-06 14:04 ESTNewsIronwood Pharmaceuticals EPS beats by $0.03, misses on revenue; reaffirms guidanceN/A
2021-05-06 14:04 ESTNewsIronwood Pharmaceuticals announces $150M share buybackN/A
2021-05-05 18:07 ESTNewsIronwood Pharmaceuticals Q1 2021 Earnings PreviewN/A

About Ironwood Pharmaceuticals, Inc (IRWD):

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist, which is in pre-clinical development for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

See Advanced Chart

General

  • Name Ironwood Pharmaceuticals, Inc
  • Symbol IRWD
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 232
  • Last Split Factor1194:1000
  • Last Split Date2019-04-02
  • Fiscal Year EndDecember
  • IPO Date2010-02-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ironwoodpharma.com
View More

Valuation

  • Trailing PE 17
  • Forward PE 10.86
  • Price/Sales (Trailing 12 Mt.) 4.76
  • Price/Book (Most Recent Quarter) 29.63
  • Enterprise Value Revenue 5
  • Enterprise Value EBITDA 13.72
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $0.96
  • Next Year EPS Estimate $1.05
  • Next Quarter EPS Estimate $0.19
  • Profit Margin 27%
  • Operating Margin 41%
  • Return on Assets 21%
  • Revenue 389.52 million
  • Earnings Per Share $0.66
  • Revenue Per Share $2.44
  • Gross Profit 298.33 million
  • Quarterly Earnings Growth -7.6%
View More

Highlights

  • Market Capitalization 1.81 billion
  • EBITDA 161.29 million
  • PE Ratio -1.27
  • PEG Ratio -0.26
  • Analyst Target Price $11
  • Book Value Per Share $0.39
View More

Share Statistics

  • Shares Outstanding 160.96 million
  • Shares Float 140.01 million
  • % Held by Insiders 296%
  • % Held by Institutions 108.52%
  • Shares Short 17.91 million
  • Shares Short Prior Month 18.17 million
  • Short Ratio 9.23
  • Short % of Float 17%
  • Short % of Shares Outstanding 11%
View More

Technicals

  • Beta 1.35
  • 52 Week High $12.55
  • 52 Week Low $8.63
  • 50 Day Moving Average 10.2
  • 200 Day Moving Average 10.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ironwood Pharmaceuticals, Inc (IRWD) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ironwood Pharmaceuticals, Inc (IRWD) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-17$116.68 million$0.36$0.2925%
2020-09-302020-11-05$103.47 million$0.23$0.1551.32%
2020-06-302020-08-06$N/A$0.16$0.1056.1%
2020-03-312020-05-06$79.94 million$0.04$0.05-13.04%
2019-12-312020-02-13$126.3 million$0.30$0.2425%
2019-09-302019-10-31$131.17 million$0.40$0.12241.01%
2019-06-302019-07-30$102.22 million$0.10-$0.03500%
2019-03-312019-05-02$68.73 million-$0.26-$0.23-14.69%
2018-12-312019-02-13$130.69 million-$0.02-$0.1989.38%
2018-09-302018-11-06$65.69 million-$0.38-$0.20-91.63%
2018-06-302018-08-06$81.11 million-$0.28-$0.23-24.06%
2018-03-312018-05-01$69.16 million-$0.27-$0.21-25.99%
2017-12-312018-02-15$94.21 million-$0.14-$0.2031.57%
2017-09-302017-11-02$86.83 million-$0.18-$0.2425.37%
2017-06-302017-08-03$65.08 million-$0.28-$0.23-22.32%
2017-03-312017-05-08$52.17 million-$0.33-$0.21-53.99%
2016-12-312017-02-21$87.46 million-$0.12-$0.2246.07%
2016-09-302016-11-03$66.11 million-$0.18-$0.2322.21%
2016-06-302016-08-04$54.35 million-$0.16-$0.160.81%
2016-03-312016-05-09$66.04 million-$0.08-$0.1751.54%
2015-12-312016-02-18$53.31 million-$0.10-$0.1843.05%
2015-09-302015-11-03$39.57 million-$0.33-$0.20-65%
2015-06-302015-08-05$27.74 million-$0.34-$0.22-54.55%
2015-03-312015-05-05$28.93 million-$0.24-$0.23-4.35%
2014-12-312015-02-12$38.07 million-$0.27-$0.21-28.57%
2014-09-302014-11-04$16.92 million-$0.30-$0.326.25%
2014-06-302014-08-04$6.84 million-$0.44-$0.36-22.22%
2014-03-312014-04-29$14.61 million-$0.38-$0.4311.63%
2013-12-312014-01-21$5.03 million-$0.43-$0.5014%
2013-09-302013-10-22$4.93 million-$0.51-$0.5710.53%
2013-06-302013-07-23$9.66 million-$0.57-$0.6816.18%
2013-03-312013-04-23$3.26 million-$0.82-$0.64-28.13%
2012-12-312013-01-15$26.98 million-$0.41-$0.4712.77%
2012-09-302012-10-16$96.41 million$0.42$0.13223.08%
2012-06-302012-07-17$14.6 million-$0.38-$0.32-18.75%
2012-03-312012-05-01$12.25 million-$0.34-$0.24-41.67%
2011-12-312012-02-28$32.15 million-$0.07-$0.1136.36%
2011-09-302011-11-07$12.22 million-$0.21-$0.210%
2011-06-302011-08-11$11.26 million-$0.19-$0.190%
2011-03-312011-05-12$10.24 million-$0.19-$0.17-11.76%
2010-12-312011-03-03$16.77 million-$0.12-$0.1414.29%
2010-09-302010-11-04$9.06 million-$0.08-$0.1957.89%
2010-06-302010-08-05$9.19 million-$0.18-$0.195.26%
2010-03-312010-05-11$8.84 million-$0.25-$0.16-56.25%
2009-12-312010-03-30$8.4 million-$3.30-$0.20-1550%

Ironwood Pharmaceuticals, Inc (IRWD) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ironwood Pharmaceuticals, Inc (IRWD) Chart:

Ironwood Pharmaceuticals, Inc (IRWD) News:

Below you will find a list of latest news for Ironwood Pharmaceuticals, Inc (IRWD) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ironwood Pharmaceuticals, Inc (IRWD) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.55.68CALL0 9400.24TRUE00
2024-05-1752.8CALL0 8264.9TRUE00
2024-05-177.51.05CALL0 3762.2TRUE00
2024-05-17100.05CALL0 867669.79FALSE00
2024-05-1712.50.05CALL0 2130FALSE00
2024-05-17150.38CALL0 1480FALSE00
2024-05-1717.50.15CALL0 1000FALSE00
2024-05-17200.05CALL0 1520FALSE00
2024-05-1722.50.05CALL0 2930FALSE00
2024-05-17250.35CALL0 20FALSE00
2024-05-17300CALL0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750.1PUT0 250FALSE00
2024-05-177.50.25PUT0 7070.13FALSE00
2024-05-17101.8PUT0 3149128.61TRUE00
2024-05-1712.54.7PUT0 66285.21TRUE00
2024-05-17156.9PUT1 44192.59TRUE6.90
2024-05-1717.53.7PUT0 0258.72TRUE00
2024-05-17205.5PUT0 0333.64TRUE00
2024-05-1722.50PUT0 0358.93TRUE00
2024-05-17250PUT0 0362.62TRUE00
2024-05-17300PUT0 0417.63TRUE00
2024-06-212.50CALL0 0273.83TRUE00
2024-06-2150CALL0 0159.65TRUE00
2024-06-217.50CALL0 0119.15TRUE00
2024-06-21100.25CALL0 4454.92FALSE00
2024-06-2112.50CALL0 00FALSE00
2024-06-21150CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 00FALSE00
2024-06-217.53.1PUT0 255.41FALSE00
2024-06-21100PUT0 036.37TRUE00
2024-06-2112.50PUT0 0109.73TRUE00
2024-06-21150PUT0 0142.82TRUE00
2024-08-162.50CALL0 0221.42TRUE00
2024-08-1653.03CALL0 0104.69TRUE00
2024-08-167.51.4CALL0 4167.48TRUE00
2024-08-16100.45CALL0 15955.15FALSE00
2024-08-1612.50.1CALL0 3956.05FALSE00
2024-08-16150.06CALL0 820FALSE00
2024-08-1617.50.05CALL0 20FALSE00
2024-08-16201.5CALL0 10FALSE00
2024-08-1622.50CALL0 00FALSE00
2024-08-16250CALL0 00FALSE00
2024-08-16300CALL0 00FALSE00
2024-08-162.50PUT0 00FALSE00
2024-08-1650.05PUT0 5575.4FALSE00
2024-08-167.50.73PUT0 7960.71FALSE00
2024-08-16102.57PUT0 13152.34TRUE00
2024-08-1612.54.5PUT0 4373.57TRUE00
2024-08-16154.7PUT0 5082.27TRUE00
2024-08-1617.54PUT0 3118.2TRUE00
2024-08-16200PUT0 0148TRUE00
2024-08-1622.50PUT0 0181.09TRUE00
2024-08-16250PUT0 0195.27TRUE00
2024-08-16300PUT0 0176.06TRUE00
2024-11-152.57.52CALL0 1118.57TRUE00
2024-11-1553.2CALL0 069.44TRUE00
2024-11-157.50CALL0 060.17TRUE00
2024-11-15100CALL0 052.98FALSE00
2024-11-1512.50.32CALL0 3255.57FALSE00
2024-11-15150CALL0 057.24FALSE00
2024-11-1517.50CALL0 00FALSE00
2024-11-152.50PUT0 00FALSE00
2024-11-1550.89PUT0 2062.33FALSE00
2024-11-157.50.89PUT0 458.31FALSE00
2024-11-15102.65PUT0 7855.81TRUE00
2024-11-1512.50PUT0 047.14TRUE00
2024-11-15150PUT0 071.01TRUE00
2024-11-1517.50PUT0 0127.11TRUE00
2024-12-202.50CALL0 0107.44TRUE00
2024-12-2050CALL0 070.66TRUE00
2024-12-207.51.85CALL1 3056.9TRUE1.850
2024-12-20100.8CALL0 9953.35FALSE00
2024-12-2012.50.32CALL0 53053.47FALSE00
2024-12-20150.2CALL0 8754.38FALSE00
2024-12-2017.50.15CALL0 130FALSE00
2024-12-20200.25CALL0 1210FALSE00
2024-12-2022.50.05CALL0 200FALSE00
2024-12-20250.25CALL0 10FALSE00
2024-12-20300CALL0 00FALSE00
2024-12-202.50PUT0 00FALSE00
2024-12-2050.31PUT0 3264.52FALSE00
2024-12-207.51.2PUT0 2655.56FALSE00
2024-12-20102.55PUT0 3949.45TRUE00
2024-12-2012.54.96PUT0 3149.5TRUE00
2024-12-20156.32PUT0 095.56TRUE00
2024-12-2017.50PUT0 079.09TRUE00
2024-12-20200PUT0 0107.2TRUE00
2024-12-2022.50PUT0 0118.86TRUE00
2024-12-20250PUT0 0105.35TRUE00
2024-12-20300PUT0 0145.84TRUE00

Latest IRWD Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST300$11.685
Jun 13, 2022 7:59 PM EST100$11.68
Jun 13, 2022 7:59 PM EST1$11.68
Jun 13, 2022 7:59 PM EST1$11.67
Jun 13, 2022 7:59 PM EST999$11.67

Ironwood Pharmaceuticals, Inc (IRWD) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120037035/0001209191-20-037035-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000031506620001036/0000315066-20-001036-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000083423720005909/0000834237-20-005909-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000086117720000002/0000861177-20-000002-index.htm
2019-05-16SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1446847/000089914019000402/0000899140-19-000402-index.htm
2020-02-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1446847/000089914020000196/0000899140-20-000196-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000090221920000252/0000902219-20-000252-index.htm
2019-04-12PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1446847/000104746919002215/0001047469-19-002215-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1446847/000104746919002641/0001047469-19-002641-index.htm
2020-04-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1446847/000104746920002477/0001047469-20-002477-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919013536/0001104659-19-013536-index.htm
2019-03-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000110465919014911/0001104659-19-014911-index.htm
2019-03-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000110465919014912/0001104659-19-014912-index.htm
2019-03-288-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919018301/0001104659-19-018301-index.htm
2019-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919019184/0001104659-19-019184-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000110465919019466/0001104659-19-019466-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919019969/0001104659-19-019969-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919020319/0001104659-19-020319-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919026217/0001104659-19-026217-index.htm
2019-05-038-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919026821/0001104659-19-026821-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919029122/0001104659-19-029122-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919033121/0001104659-19-033121-index.htm
2019-05-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1446847/000110465919033182/0001104659-19-033182-index.htm
2019-05-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1446847/000110465919033185/0001104659-19-033185-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919035369/0001104659-19-035369-index.htm
2019-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919039823/0001104659-19-039823-index.htm
2019-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919041287/0001104659-19-041287-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919042631/0001104659-19-042631-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465919058066/0001104659-19-058066-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920003250/0001104659-20-003250-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000110465920017218/0001104659-20-017218-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920019682/0001104659-20-019682-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920033605/0001104659-20-033605-index.htm
2020-04-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1446847/000110465920049217/0001104659-20-049217-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920049220/0001104659-20-049220-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920057422/0001104659-20-057422-index.htm
2020-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920070834/0001104659-20-070834-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920091113/0001104659-20-091113-index.htm
2020-09-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920109500/0001104659-20-109500-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000110465920121800/0001104659-20-121800-index.htm
2020-11-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1446847/000110465920122016/0001104659-20-122016-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000114420419030427/0001144204-19-030427-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119017301/0001209191-19-017301-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119017305/0001209191-19-017305-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119017525/0001209191-19-017525-index.htm
2019-03-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119018232/0001209191-19-018232-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119020265/0001209191-19-020265-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119020268/0001209191-19-020268-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023411/0001209191-19-023411-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023416/0001209191-19-023416-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023419/0001209191-19-023419-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023423/0001209191-19-023423-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023427/0001209191-19-023427-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023429/0001209191-19-023429-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/0001209191-19-023430-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023431/0001209191-19-023431-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023433/0001209191-19-023433-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023438/0001209191-19-023438-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023456/0001209191-19-023456-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023457/0001209191-19-023457-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023458/0001209191-19-023458-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023459/0001209191-19-023459-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023462/0001209191-19-023462-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023463/0001209191-19-023463-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119023482/0001209191-19-023482-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119027346/0001209191-19-027346-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119029596/0001209191-19-029596-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119029601/0001209191-19-029601-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119029605/0001209191-19-029605-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119029609/0001209191-19-029609-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033615/0001209191-19-033615-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033621/0001209191-19-033621-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033624/0001209191-19-033624-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033627/0001209191-19-033627-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033630/0001209191-19-033630-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033633/0001209191-19-033633-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033637/0001209191-19-033637-index.htm
2019-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119033645/0001209191-19-033645-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119035509/0001209191-19-035509-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119035513/0001209191-19-035513-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119037676/0001209191-19-037676-index.htm
2019-07-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119041824/0001209191-19-041824-index.htm
2019-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119041827/0001209191-19-041827-index.htm
2019-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119043685/0001209191-19-043685-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119046846/0001209191-19-046846-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm
2019-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119049666/0001209191-19-049666-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119056188/0001209191-19-056188-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119056191/0001209191-19-056191-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119060843/0001209191-19-060843-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119061129/0001209191-19-061129-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119061132/0001209191-19-061132-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119061134/0001209191-19-061134-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119061135/0001209191-19-061135-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919119061136/0001209191-19-061136-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120004301/0001209191-20-004301-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120004855/0001209191-20-004855-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120005129/0001209191-20-005129-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120006267/0001209191-20-006267-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120012490/0001209191-20-012490-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120012528/0001209191-20-012528-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120014402/0001209191-20-014402-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120014464/0001209191-20-014464-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120014467/0001209191-20-014467-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120014476/0001209191-20-014476-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120019543/0001209191-20-019543-index.htm
2020-04-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120025240/0001209191-20-025240-index.htm
2020-04-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120025241/0001209191-20-025241-index.htm
2020-04-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120025257/0001209191-20-025257-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120025917/0001209191-20-025917-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120025918/0001209191-20-025918-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120028895/0001209191-20-028895-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120028899/0001209191-20-028899-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120028900/0001209191-20-028900-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120028903/0001209191-20-028903-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120028906/0001209191-20-028906-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034692/0001209191-20-034692-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034693/0001209191-20-034693-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034694/0001209191-20-034694-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034695/0001209191-20-034695-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034696/0001209191-20-034696-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034697/0001209191-20-034697-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034699/0001209191-20-034699-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120034700/0001209191-20-034700-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120036289/0001209191-20-036289-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120037035/0001209191-20-037035-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120047469/0001209191-20-047469-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120047472/0001209191-20-047472-index.htm
2020-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120049868/0001209191-20-049868-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120050875/0001209191-20-050875-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1446847/000120919120054621/0001209191-20-054621-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000127417320000094/0001274173-20-000094-index.htm
2019-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000139834419016261/0001398344-19-016261-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1446847/000139834420003413/0001398344-20-003413-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000141057819000630/0001410578-19-000630-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000141057819000770/0001410578-19-000770-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000141057819000778/0001410578-19-000778-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000141057819001260/0001410578-19-001260-index.htm
2019-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1446847/000141057819001289/0001410578-19-001289-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837019003848/0001558370-19-003848-index.htm
2019-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837019006578/0001558370-19-006578-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837019009567/0001558370-19-009567-index.htm
2020-02-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1446847/000155837020000779/0001558370-20-000779-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837020005460/0001558370-20-005460-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837020009637/0001558370-20-009637-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1446847/000155837020012918/0001558370-20-012918-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1446847/999999999719001495/9999999997-19-001495-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1446847/999999999719003532/9999999997-19-003532-index.htm
2019-04-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1446847/999999999719003534/9999999997-19-003534-index.htm

Ironwood Pharmaceuticals, Inc (IRWD) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ironwood Pharmaceuticals, Inc (IRWD). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 296%
Institutional Ownership: 10852%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-04-01Mark MallonChief Executive OfficerBuy11,500.00104,536.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023482/0001209191-19-023482-index.htm
2020-04-24Michael ShetzlineCMO, SVP & Head of Drug Devt.Buy20,740.00107,046.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120025918/0001209191-20-025918-index.htm
2019-05-10Thomas A MCCOURTPresidentSell4,055.0010.5342,699.15107,239.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119029609/0001209191-19-029609-index.htm
2020-06-03Andrew DreyfusDirectorBuy21,720.00108,658.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034693/0001209191-20-034693-index.htm
2019-06-05Julie McHughDirectorSell1,500.0011.2616,890.00109,337.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119035509/0001209191-19-035509-index.htm
2019-08-30Thomas A MCCOURTPresidentSell220,000.009.242,032,800.00109,739.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm
2020-06-15Andrew DreyfusDirectorBuy1,745.00110,403.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120037035/0001209191-20-037035-index.htm
2019-05-29Julie McHughDirectorBuy22,706.00110,837.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033630/0001209191-19-033630-index.htm
2019-05-01Thomas A MCCOURTPresidentBuy22,852.00111,294.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119027346/0001209191-19-027346-index.htm
2020-09-15Andrew DreyfusDirectorBuy1,600.00112,003.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120050875/0001209191-20-050875-index.htm
2020-05-11Kelly MacDonaldChief Accounting OfficerSell595.0010.356,158.25118,147.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028899/0001209191-20-028899-index.htm
2020-08-17Kelly MacDonaldChief Accounting OfficerSell575.0010.145,830.50118,552.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120047469/0001209191-20-047469-index.htm
2020-05-11Kelly MacDonaldChief Accounting OfficerSell558.0010.355,775.30118,742.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028899/0001209191-20-028899-index.htm
2020-02-27Kelly MacDonaldChief Accounting OfficerBuy36,173.00119,300.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120014464/0001209191-20-014464-index.htm
2020-09-08Julie McHughDirectorSell7,950.009.7777,671.50123,107.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120049868/0001209191-20-049868-index.htm
2020-05-11Conor KilroySVP, GC & SecretarySell558.0010.355,775.30128,921.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028895/0001209191-20-028895-index.htm
2020-05-11Conor KilroySVP, GC & SecretarySell158.0010.351,635.30129,479.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028895/0001209191-20-028895-index.htm
2020-04-24Conor KilroySVP, GC & SecretaryBuy22,814.00129,637.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120025917/0001209191-20-025917-index.htm
2020-06-03Julie McHughDirectorBuy21,720.00131,057.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034696/0001209191-20-034696-index.htm
2019-04-01Marsha FanucciDirectorSell4,056.00132,663.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023411/0001209191-19-023411-index.htm
2019-03-29IRONWOOD PHARMACEUTICALS INC10% Share HolderBuy15,562,455.0015,562,555.00https://www.sec.gov/Archives/edgar/data/1446847/000110465919019466/0001104659-19-019466-index.htm
2019-11-08Gina ConsylmanSVP, CFO & TreasurerSell630.0011.006,930.00174,138.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119056188/0001209191-19-056188-index.htm
2019-11-08Gina ConsylmanSVP, CFO & TreasurerSell880.0011.009,680.00174,768.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119056188/0001209191-19-056188-index.htm
2019-08-16Gina ConsylmanSVP, CFO & TreasurerSell212.009.041,916.48175,648.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119046846/0001209191-19-046846-index.htm
2019-05-10Gina ConsylmanSVP, CFO & TreasurerSell4,055.0010.5342,699.15175,860.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119029596/0001209191-19-029596-index.htm
2019-04-01Gina ConsylmanSVP, CFO & TreasurerBuy16,731.00179,915.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023430/0001209191-19-023430-index.htm
2019-05-29Edward P OwensDirectorBuy22,706.00182,234.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033645/0001209191-19-033645-index.htm
2019-08-30Thomas A MCCOURTPresidentBuy90,000.004.88439,200.00199,739.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm
2020-02-21Gina ConsylmanSVP, CFO & TreasurerSell6,181.0011.6371,885.03202,787.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm
2020-06-03Edward P OwensDirectorBuy21,720.00203,954.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034700/0001209191-20-034700-index.htm
2020-02-21Gina ConsylmanSVP, CFO & TreasurerSell2,558.0011.6329,749.54208,968.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm
2020-02-21Gina ConsylmanSVP, CFO & TreasurerSell2,252.0011.6326,190.76211,526.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm
2020-02-21Gina ConsylmanSVP, CFO & TreasurerSell1,510.0011.6317,561.30213,778.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012474/0001209191-20-012474-index.htm
2019-12-16Gina ConsylmanSVP, CFO & TreasurerBuy41,150.00215,288.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119061129/0001209191-19-061129-index.htm
2020-02-21Thomas A MCCOURTPresidentSell1,865.0011.6321,689.95221,062.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012490/0001209191-20-012490-index.htm
2020-02-21Thomas A MCCOURTPresidentSell2,312.0011.6326,888.56222,927.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012490/0001209191-20-012490-index.htm
2019-12-16Thomas A MCCOURTPresidentBuy115,220.00224,959.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119061135/0001209191-19-061135-index.htm
2020-01-24Thomas A MCCOURTPresidentSell20,000.0012.71254,200.00225,239.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120005129/0001209191-20-005129-index.htm
2020-05-11Jason RickardSVP, Chief Operating OfficerSell510.0010.355,278.50234,580.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028906/0001209191-20-028906-index.htm
2020-08-17Jason RickardSVP, Chief Operating OfficerSell689.0010.146,986.46235,776.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120047472/0001209191-20-047472-index.htm
2019-05-10Halley E GilbertChief Admin Officer & SVPSell4,055.0010.5342,699.15238,240.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119029605/0001209191-19-029605-index.htm
2019-07-26Halley E GilbertChief Admin Officer & SVPSell20,000.0010.00200,000.00240,169.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119043685/0001209191-19-043685-index.htm
2019-04-01Halley E GilbertChief Admin Officer & SVPBuy17,165.00242,295.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023431/0001209191-19-023431-index.htm
2020-01-24Thomas A MCCOURTPresidentBuy20,000.0010.02200,400.00245,239.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120005129/0001209191-20-005129-index.htm
2019-05-29Catherine MoukheibirDirectorBuy22,706.0025,701.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033633/0001209191-19-033633-index.htm
2019-05-29Jon R DuaneDirectorBuy22,706.0025,701.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033624/0001209191-19-033624-index.htm
2019-05-29Marla L KesslerDirectorBuy22,706.0025,701.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033627/0001209191-19-033627-index.htm
2019-07-26Halley E GilbertChief Admin Officer & SVPBuy20,000.004.8897,600.00260,169.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119043685/0001209191-19-043685-index.htm
2019-04-01William HuyettChief Operating OfficerSell85,312.0026,063.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023429/0001209191-19-023429-index.htm
2020-02-21Halley E GilbertChief Admin Officer & SVPSell6,181.0011.6371,885.03265,991.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm
2020-02-27Gina ConsylmanSVP, CFO & TreasurerBuy68,327.00271,114.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120014402/0001209191-20-014402-index.htm
2020-02-21Halley E GilbertChief Admin Officer & SVPSell2,984.0011.6334,703.92272,172.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm
2020-02-21Halley E GilbertChief Admin Officer & SVPSell3,410.0011.6339,658.30275,156.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm
2019-04-01William HuyettChief Operating OfficerBuy1,483.0027,546.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023429/0001209191-19-023429-index.htm
2020-02-21Halley E GilbertChief Admin Officer & SVPSell2,753.0011.6332,017.39278,566.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012479/0001209191-20-012479-index.htm
2019-12-16Halley E GilbertChief Admin Officer & SVPBuy41,150.00281,319.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119061132/0001209191-19-061132-index.htm
2020-01-31Halley E GilbertChief Admin Officer & SVPSell60,000.0012.05723,000.00281,319.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120006267/0001209191-20-006267-index.htm
2019-04-01Catherine MoukheibirDirectorBuy2,995.002,995.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023463/0001209191-19-023463-index.htm
2019-04-01Jon R DuaneDirectorBuy2,995.002,995.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023457/0001209191-19-023457-index.htm
2019-04-01Marla L KesslerDirectorBuy2,995.002,995.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023459/0001209191-19-023459-index.htm
2020-02-24Mark MallonChief Executive OfficerSell1.0011.2511.25303,425.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012528/0001209191-20-012528-index.htm
2020-02-21Mark MallonChief Executive OfficerSell7,983.0011.6392,842.29303,426.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012528/0001209191-20-012528-index.htm
2019-04-01Mark MallonChief Executive OfficerBuy206,873.00311,409.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023482/0001209191-19-023482-index.htm
2020-05-11Thomas A MCCOURTPresidentSell1,697.0010.3517,563.95319,847.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028903/0001209191-20-028903-index.htm
2020-02-27Thomas A MCCOURTPresidentBuy100,482.00321,544.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120014476/0001209191-20-014476-index.htm
2019-08-30Thomas A MCCOURTPresidentBuy130,000.004.88634,400.00329,739.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119048225/0001209191-19-048225-index.htm
2020-01-31Halley E GilbertChief Admin Officer & SVPBuy60,000.0010.02601,200.00341,319.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120006267/0001209191-20-006267-index.htm
2019-03-05LAWRENCE S OLANOFFDirectorSell2,000.0014.4128,820.0037,553.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119017301/0001209191-19-017301-index.htm
2019-04-01AMY W SCHULMANDirectorSell4,056.0038,242.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023419/0001209191-19-023419-index.htm
2019-03-15AMY W SCHULMANDirectorBuy183.0042,298.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119020265/0001209191-19-020265-index.htm
2020-06-03Catherine MoukheibirDirectorBuy21,720.0047,421.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034697/0001209191-20-034697-index.htm
2020-06-03Jon R DuaneDirectorBuy21,720.0047,421.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034694/0001209191-20-034694-index.htm
2020-06-03Marla L KesslerDirectorBuy21,720.0047,421.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034695/0001209191-20-034695-index.htm
2020-05-11Mark MallonChief Executive OfficerSell23,206.0010.35240,182.10501,280.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120028900/0001209191-20-028900-index.htm
2020-02-27Mark MallonChief Executive OfficerBuy221,061.00524,486.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120014467/0001209191-20-014467-index.htm
2019-03-08Mark G CurrieChief Scientific OfficerSell49,500.0013.15650,925.00528,480.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119018232/0001209191-19-018232-index.htm
2019-05-10Mark G CurrieDirectorSell4,055.0010.5342,699.15528,903.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119029601/0001209191-19-029601-index.htm
2019-04-01Mark G CurrieDirectorBuy1,483.00529,963.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023438/0001209191-19-023438-index.htm
2019-04-01Mark G CurrieDirectorBuy2,995.00532,958.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023438/0001209191-19-023438-index.htm
2020-01-16Mark G CurrieDirectorSell8,888.0012.80113,766.40549,272.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120004301/0001209191-20-004301-index.htm
2020-01-23Mark G CurrieDirectorSell60,000.0012.59755,400.00549,272.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120004855/0001209191-20-004855-index.htm
2019-05-29Mark G CurrieDirectorBuy22,706.00551,609.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033615/0001209191-19-033615-index.htm
2020-01-16Mark G CurrieDirectorBuy8,888.0010.0289,057.76558,160.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120004301/0001209191-20-004301-index.htm
2020-06-03Mark G CurrieDirectorBuy21,720.00570,992.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034692/0001209191-20-034692-index.htm
2019-03-07Mark G CurrieChief Scientific OfficerSell225,500.0013.292,996,895.00577,980.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119018232/0001209191-19-018232-index.htm
2019-06-05LAWRENCE S OLANOFFDirectorSell2,000.0011.2522,500.0058,259.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119035513/0001209191-19-035513-index.htm
2019-05-29LAWRENCE S OLANOFFDirectorBuy22,706.0060,259.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033637/0001209191-19-033637-index.htm
2020-01-23Mark G CurrieDirectorBuy60,000.009.12547,200.00609,272.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120004855/0001209191-20-004855-index.htm
2020-06-10LAWRENCE S OLANOFFDirectorSell11,350.0010.06114,181.0068,629.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120036289/0001209191-20-036289-index.htm
2019-04-01TERRANCE MCGUIREDirectorSell4,056.0073,630.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023416/0001209191-19-023416-index.htm
2019-03-15TERRANCE MCGUIREDirectorBuy183.0077,686.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119020268/0001209191-19-020268-index.htm
2019-11-08Kelly MacDonaldChief Accounting OfficerSell107.0011.001,177.0078,337.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119056191/0001209191-19-056191-index.htm
2019-11-08Kelly MacDonaldChief Accounting OfficerSell880.0011.009,680.0078,444.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119056191/0001209191-19-056191-index.htm
2019-07-09Kelly MacDonaldChief Accounting OfficerBuy7,500.0079,324.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119041827/0001209191-19-041827-index.htm
2020-06-03LAWRENCE S OLANOFFDirectorBuy21,720.0079,979.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120034699/0001209191-20-034699-index.htm
2019-05-29Andrew DreyfusDirectorBuy22,706.0080,813.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119033621/0001209191-19-033621-index.htm
2019-06-14Andrew DreyfusDirectorBuy1,567.0082,380.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119037676/0001209191-19-037676-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell1,695.0011.6319,712.8583,127.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2019-09-13Andrew DreyfusDirectorBuy1,692.0084,072.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119049666/0001209191-19-049666-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell303.0011.633,523.8984,822.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell793.0011.639,222.5985,125.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2019-12-13Andrew DreyfusDirectorBuy1,270.0085,342.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119060843/0001209191-19-060843-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell303.0011.633,523.8985,918.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell504.0011.635,861.5286,221.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2019-12-16Kelly MacDonaldChief Accounting OfficerBuy8,230.0086,567.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119061134/0001209191-19-061134-index.htm
2020-02-21Kelly MacDonaldChief Accounting OfficerSell302.0011.633,512.2686,725.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120012484/0001209191-20-012484-index.htm
2020-03-13Andrew DreyfusDirectorBuy1,596.0086,938.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120019543/0001209191-20-019543-index.htm
2019-04-01DOUGLAS E WILLIAMSDirectorSell4,056.0087,800.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023423/0001209191-19-023423-index.htm
2019-03-05Julie McHughDirectorSell1,500.0014.3821,570.0088,131.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119017305/0001209191-19-017305-index.htm
2019-04-01Thomas A MCCOURTPresidentBuy5,133.0088,442.00https://www.sec.gov/Archives/edgar/data/1446847/000120919119023433/0001209191-19-023433-index.htm
2020-10-08Kelly MacDonaldChief Accounting OfficerSell22,714.0010.50238,497.0095,838.00https://www.sec.gov/Archives/edgar/data/1446847/000120919120054621/0001209191-20-054621-index.htm